Expanding the potential for epigenetic targeting therapies in prostate cancer: HDAC inhibition sensitises to radiotherapy

Research output: Contribution to conferencePoster

Original languageEnglish
Publication statusPublished - 2017
EventEuropean Alliance for Personalised Medicine Conference : “Personalising your Health: A Global Imperative” - Belfast, United Kingdom
Duration: 25 Nov 201729 Nov 2017

Conference

ConferenceEuropean Alliance for Personalised Medicine Conference
CountryUnited Kingdom
CityBelfast
Period25/11/201729/11/2017

Keywords

  • Prostate Cancer
  • Epigenetic
  • Entinostat

Cite this

Manley, J., Maxwell, P., Longley, D., Waugh, D., & LaBonte Wilson, M. (2017). Expanding the potential for epigenetic targeting therapies in prostate cancer: HDAC inhibition sensitises to radiotherapy. Poster session presented at European Alliance for Personalised Medicine Conference , Belfast, United Kingdom.